Pharmaceutical News

RSS

KFF Health News' 'What the Health?': Biden wins early court test for Medicare drug negotiations

A federal judge in Texas has turned back the first challenge to the nascent Medicare prescription-drug negotiation program.

15 Feb 2024

Pharmacists join doctors and patients to slash medication-related errors in hospitals

Pharmacists will partner with patients and doctors in a new national project to reduce patient medication errors that frequently occur during hospital stays.

13 Feb 2024

Oral azithromycin reduces maternal sepsis and healthcare costs in low-resource settings

Sepsis, a severe infection that can lead to tissue damage, organ failure, and death, is one of the top three causes of maternal deaths worldwide, according to the World Health Organization.

12 Feb 2024

University of Michigan's pharmacist-centric care model replicated by CDC to tackle hypertension

Embedding pharmacists as part of the health care team at University of Michigan primary care clinics and community retail pharmacies has proven so effective in controlling blood pressure that the Centers for Disease Control and Prevention is now replicating the model of care and expanding it to the southeastern United States.

12 Feb 2024

Drug repurposing study finds lonafarnib effective against RSV

A study in Nature Communications identifies lonafarnib from the ReFRAME drug-repurposing library as a potent inhibitor of the RSV fusion protein, showing promise in reducing RSV infection in vitro and in vivo.

11 Feb 2024

New study finds 4’-fluorouridine effective against avian influenza in vitro and in vivo

A PLOS Pathogens study reveals 4’-fluorouridine effectively combats avian influenza in vitro and in animal models, showing promise as a treatment that overcomes resistance and reduces disease severity without significant adverse effects.

11 Feb 2024

IPIAD augments standard therapy for pancreatic ductal adenocarcinoma

A new research perspective was published in Oncoscience (Volume 11) on February 7, 2024, entitled, "IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone."

9 Feb 2024

UH Brain Health & Memory Center now treating patients with FDA-approved drug for Alzheimer's disease

University Hospitals (UH) Brain Health & Memory Center is now treating patients with LEQEMBI (lecanemab), a Food and Drug Administration-approved medication for the treatment of Alzheimer's disease.

9 Feb 2024

Rucaparib and its major metabolite exhibit differential biological activity and synergy

Once they enter the body, drugs, apart from carrying out their therapeutic function, are biochemically transformed by the action of the metabolic machinery, a process that facilitates their expulsion.

9 Feb 2024

LSHTM researchers receive £2m funding to develop novel vaccines, diagnostics and therapeutics

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2m funding through the UK Research and Innovation's (UKRI) Technology Missions Fund, to develop novel vaccines, diagnostics and therapeutics.

9 Feb 2024

MHRA authorizes COVID-19 vaccines: Comirnaty and Nuvaxovid gain approvals

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a change to the license of the Comirnaty Omicron XBB.1.5 30 micrograms/dose (single-dose vials) after it was found to meet the UK regulator's standards of safety, quality and effectiveness.

9 Feb 2024

Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds

The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR).

9 Feb 2024

Vaccines safe for pregnant women with HIV but show reduced immune response

A meta-analysis in eClinicalMedicine finds vaccines are safe for pregnant women living with HIV, showing reduced immunogenicity compared to those without HIV but no increase in adverse events, highlighting the need for their inclusion in vaccine trials.

9 Feb 2024

mRNA COVID vaccines in pregnancy linked to lower risk of neonatal issues, study shows

A JAMA Network study finds COVID-19 mRNA vaccines in pregnant women not only safe but also associated with reduced risks of neonatal cerebral ischemia, intracranial hemorrhage, and mortality, supporting vaccination during pregnancy.

9 Feb 2024

New treatment targeting aging cells could offer lasting relief for diabetic macular edema

Targeting senescent cells in the retina with a BCL-xL inhibitor shows promise as a durable treatment for diabetic macular edema, potentially offering long-term visual function improvements.

8 Feb 2024

Intravenous DMT shows promise in reducing depression symptoms, study reveals

A study in Scientific Reports shows intravenous DMT can significantly reduce depression severity in healthy volunteers, highlighting its potential as a therapeutic psychedelic intervention for mental health disorders.

8 Feb 2024

Hope for relapsed myeloma: Preclinical and clinical evidence for ruxolitinib's efficacy

A new research perspective was published in Oncotarget's Volume 15 on February 5, 2024, entitled, "Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma."

8 Feb 2024

Study shows link between erectile dysfunction drugs and reduced risk of Alzheimer’s

The drugs used to treat erectile dysfunction may also be associated with a reduced risk of Alzheimer's disease, according to a study published in the February 7, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

7 Feb 2024

AMG 133 (maridebart cafraglutide) weight loss drug shows promise in early trial

AMG 133, an engineered bispecific molecule, demonstrated significant weight loss with a favorable safety profile in a phase 1 clinical trial, offering a promising new treatment option for obesity.

7 Feb 2024

Quest Pharm and Aston University develop world-first tablet to treat mouth ulcerations in chemotherapy patients

A Knowledge Transfer Partnership (KTP) between UK pharmaceutical company Quest Pharm and Aston University has developed a world-first tablet to treat the serious mouth ulcerations caused by high-dose chemotherapy.

7 Feb 2024

Previous
1
...
24
25
26
27
28
29
30
...
1433
Next

Pharmaceutical News

KFF Health News' 'What the Health?': Biden wins early court test for Medicare drug negotiations

Pharmacists join doctors and patients to slash medication-related errors in hospitals

Oral azithromycin reduces maternal sepsis and healthcare costs in low-resource settings

University of Michigan's pharmacist-centric care model replicated by CDC to tackle hypertension

Drug repurposing study finds lonafarnib effective against RSV

New study finds 4’-fluorouridine effective against avian influenza in vitro and in vivo

IPIAD augments standard therapy for pancreatic ductal adenocarcinoma

UH Brain Health & Memory Center now treating patients with FDA-approved drug for Alzheimer's disease

Rucaparib and its major metabolite exhibit differential biological activity and synergy

LSHTM researchers receive £2m funding to develop novel vaccines, diagnostics and therapeutics

MHRA authorizes COVID-19 vaccines: Comirnaty and Nuvaxovid gain approvals

Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds

Vaccines safe for pregnant women with HIV but show reduced immune response

mRNA COVID vaccines in pregnancy linked to lower risk of neonatal issues, study shows

New treatment targeting aging cells could offer lasting relief for diabetic macular edema

Intravenous DMT shows promise in reducing depression symptoms, study reveals

Hope for relapsed myeloma: Preclinical and clinical evidence for ruxolitinib's efficacy

Study shows link between erectile dysfunction drugs and reduced risk of Alzheimer’s

AMG 133 (maridebart cafraglutide) weight loss drug shows promise in early trial

Quest Pharm and Aston University develop world-first tablet to treat mouth ulcerations in chemotherapy patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News